We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

63 hedge funds and large institutions have $173M invested in Alpine Immune Sciences Inc in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 8

54% more funds holding

Funds holding: 41 → 63 (+22)

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

6% less capital invested

Capital invested by funds: $183M → $173M (-$10.1M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
63
Holders Change
+22
Holders Change %
+53.66%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
13
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TM
Tiger Management
New York
+$10.7M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$8.48M
3
OM
Opaleye Management
Massachusetts
+$2.88M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.63M
5
PA
Perceptive Advisors
New York
+$2.05M

Top Sellers

Rank Fund Capital Flow
1
LCP
Lamond Capital Partners
California
-$3.41M
2
RCM
RA Capital Management
Massachusetts
-$2.37M
3
BA
BlackRock Advisors
Delaware
-$2.16M
4
DCM
Driehaus Capital Management
Illinois
-$2.04M
5
PCM
Pentwater Capital Management
Florida
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$811K – – –
GP
27
GLG Partners
United Kingdom
$751K +$437K +6,654 +85%
FAM
28
Fred Alger Management
New York
$745K – – –
Alyeska Investment Group
29
Alyeska Investment Group
Illinois
$636K +$394K +6,002 +96%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$561K +$711K +10,816 New
PAM
31
Panagora Asset Management
Massachusetts
$460K +$582K +8,861 New
Morgan Stanley
32
Morgan Stanley
New York
$454K +$575K +8,753 New
ECM
33
Endurant Capital Management
California
$393K -$266K -4,054 -35%
RI
34
RTW Investments
New York
$389K – – –
BM
35
Bridger Management
New York
$381K – – –
USAA
36
United Services Automobile Association
Texas
$295K +$109K +1,663 +41%
SIM
37
Spark Investment Management
New York
$286K +$361K +5,500 New
Geode Capital Management
38
Geode Capital Management
Massachusetts
$277K +$352K +5,350 New
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$264K +$334K +5,091 New
NIP
40
Nicholas Investment Partners
California
$258K +$118K +1,800 +57%
VKH
41
Virtu KCG Holdings
New York
$208K +$263K +4,008 New
CS
42
Credit Suisse
Switzerland
$205K +$259K +3,949 New
BIM
43
BlackRock Investment Management
Delaware
$199K +$111K +1,684 +78%
DCM
44
DAFNA Capital Management
California
$195K – – –
Northern Trust
45
Northern Trust
Illinois
$186K +$236K +3,593 New
Millennium Management
46
Millennium Management
New York
$185K +$235K +3,572 New
Bank of New York Mellon
47
Bank of New York Mellon
New York
$157K +$199K +3,023 New
AC
48
Ascend Capital
California
$156K +$195K +2,974 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$119K +$151K +2,300 New
TRCT
50
Tower Research Capital (TRC)
New York
$110K +$139K +2,119 New
1
2
3

ALPN Hedge Fund Activity: Q3 2015 in Review

63 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q3 2015, worth a combined $173M — down 5.5% from $183M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ALPN positions and 8 closed out — a net gain of 22 holders — while 13 added to existing stakes and 13 trimmed.

The largest buyer was Tiger Management, opening a new position worth an estimated $10.7M. The largest seller was Lamond Capital Partners, exiting entirely with an estimated $3.41M sold.

  • 63 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q3 2015, up from 41 in Q2 2015.
  • Funds reported $173M of Alpine Immune Sciences Inc stock for Q3 2015, down 5.5% quarter-over-quarter.
  • 30 funds opened new Alpine Immune Sciences Inc positions in Q3 2015 and 8 closed out, a net change of +22 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q3 2015 was Tiger Management, an estimated $10.7M added.
  • The largest Alpine Immune Sciences Inc seller in Q3 2015 was Lamond Capital Partners, an estimated $3.41M sold.

Based on aggregated 13F filings for Q3 2015.